Loading data
STRTNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 579.39 m USD | 565.07 m USD | 537.77 m USD | 492.95 m USD | 452.27 m USD |
| Cost of revenue | 484.03 m USD | 480.49 m USD | 472.3 m USD | 450.79 m USD | 396.25 m USD |
| Gross profit | 95.37 m USD | 84.58 m USD | 65.47 m USD | 42.15 m USD | 56.02 m USD |
| Research and development expense | 21.8 m USD | 21.7 m USD | 14.8 m USD | 15.9 m USD | 12.2 m USD |
| Operating profit | 26.52 m USD | 22.78 m USD | 17.81 m USD | -6.09 m USD | 8.9 m USD |
| Interest expense | 359 k USD | 1.01 m USD | 900 k USD | 960 k USD | 221 k USD |
| Profit before tax | 32.96 m USD | 24.64 m USD | 20.2 m USD | -7.67 m USD | 9.26 m USD |
| Income tax expense | 11.34 m USD | 5.72 m USD | 3.78 m USD | 1.28 m USD | 415 k USD |
| Net income (reported basis) | 20.6 m USD | 18.69 m USD | 16.31 m USD | -6.67 m USD | 7.02 m USD |
| Basic earnings per share | 5.07 USD/share | 4.64 USD/share | 4.1 USD/share | -1.7 USD/share | 1.82 USD/share |
| Diluted earnings per share | 5 USD/share | 4.58 USD/share | 4.07 USD/share | -1.7 USD/share | 1.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.